Totaligent's Revenue Vanishes, Net Loss Widens Amid Going Concern Doubts

TL;DR

**TGNT is a zombie company with no revenue and a massive deficit; avoid at all costs.**

AI Summary

Totaligent, Inc. (TGNT) reported a significant decline in revenue, generating $0 for the three and six months ended June 30, 2025, a sharp drop from $73,610 and $414,539 in the comparable 2024 periods, respectively. This led to a gross profit of $0 for both periods in 2025, down from $36,078 and $79,929 in 2024. The company's net loss for the six months ended June 30, 2025, widened to $373,472, compared to a net loss of $264,292 for the same period in 2024. Operating expenses decreased slightly to $182,528 for the six months ended June 30, 2025, from $353,237 in 2024, primarily due to reduced personnel and consulting expenses. Totaligent's cash position improved to $62,626 as of June 30, 2025, from $22,128 at December 31, 2024, largely due to $230,000 in proceeds from convertible notes payable. However, the company faces substantial doubt about its ability to continue as a going concern, evidenced by a negative working capital of $2,138,934 and an accumulated deficit of $2,180,835 as of June 30, 2025. Strategic outlook remains uncertain as the company is dependent on securing additional debt or equity financing to fund operations and achieve commercial viability.

Why It Matters

Totaligent's complete lack of revenue in Q2 2025, a stark contrast to the prior year, signals a critical failure in its business model and raises severe questions about its operational viability. For investors, this indicates extreme risk and potential for total loss, as the company is entirely reliant on external financing to survive, with a negative working capital of $2,138,934. Employees face job insecurity given the company's inability to generate sales and its significant accumulated deficit of $2,180,835. Customers, if any, would be impacted by the instability of a company unable to sustain operations. In the broader market, this highlights the challenges faced by small, unproven digital marketing platforms in a competitive landscape, underscoring the importance of sustainable revenue generation.

Risk Assessment

Risk Level: high — Totaligent exhibits a high risk level due to its complete absence of revenue for the three and six months ended June 30, 2025, coupled with a net loss of $373,472 for the six-month period. The company also reported a negative working capital of $2,138,934 and an accumulated deficit of $2,180,835 as of June 30, 2025, leading management to conclude there is "substantial doubt about the Company's ability to continue as a going concern."

Analyst Insight

Investors should immediately divest any holdings in TGNT or avoid initiating a position. The company's inability to generate revenue and its significant financial distress, including a substantial accumulated deficit and negative working capital, indicate a high probability of failure. Focus on companies with proven revenue streams and positive cash flow.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$245,070

total Debt

$911,335

net Income

$-373,472

eps

N/A

gross Margin

N/A

cash Position

$62,626

revenue Growth

-100.0%

Revenue Breakdown

Key Numbers

• $0 — Revenue (For the three and six months ended June 30, 2025, down from $73,610 and $414,539 respectively in 2024.)
• $(373,472) — Net Loss (For the six months ended June 30, 2025, widened from $(264,292) in 2024.)
• $(2,138,934) — Negative Working Capital (As of June 30, 2025, indicating severe liquidity issues.)
• $(2,180,835) — Accumulated Deficit (As of June 30, 2025, reflecting significant historical losses.)
• $62,626 — Cash (As of June 30, 2025, an increase from $22,128 at December 31, 2024, primarily from debt financing.)
• $230,000 — Proceeds from Convertible Notes Payable (For the six months ended June 30, 2025, the primary source of cash inflow.)
• 211,101,313 — Shares Outstanding (As of August 13, 2025, indicating potential for significant dilution with future equity raises.)
• $3.7 million — Market Value of Non-Affiliate Common Stock (As of June 30, 2025, reflecting a very small market capitalization.)

Key Players & Entities

• Totaligent, Inc. (company) — Registrant and parent company
• Digi Messaging & Advertising Inc. (company) — Wholly owned subsidiary of Totaligent
• Edward C. DeFeudis (person) — Appointed CEO of Totaligent on July 21, 2022
• Ben Hansel (person) — Remained on the board of directors after the merger
• Securities and Exchange Commission (regulator) — Regulates financial reporting for public companies
• $0 (dollar_amount) — Revenue for the three and six months ended June 30, 2025
• $373,472 (dollar_amount) — Net loss for the six months ended June 30, 2025
• $2,138,934 (dollar_amount) — Negative working capital as of June 30, 2025
• $2,180,835 (dollar_amount) — Accumulated deficit as of June 30, 2025
• $62,626 (dollar_amount) — Cash balance as of June 30, 2025

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: The company faces substantial doubt about its ability to continue as a going concern due to a negative working capital of $2,138,934 and an accumulated deficit of $2,180,835 as of June 30, 2025. Operations are dependent on securing additional financing.
• Revenue Collapse [high — financial]: Revenue dropped to $0 for the three and six months ended June 30, 2025, from $73,610 and $414,539 in the prior year periods. This complete loss of revenue stream severely impacts the company's ability to generate cash and fund operations.
• Dependence on Financing [high — financial]: Totaligent is critically dependent on securing additional debt or equity financing to fund its operations and achieve commercial viability. Failure to obtain necessary funding will likely lead to cessation of operations.
• Dilution Risk [medium — financial]: With 211,101,313 shares outstanding as of August 13, 2025, and a market value of $3.7 million as of June 30, 2025, future equity raises to fund operations carry a significant risk of substantial dilution for existing shareholders.
• Increased Net Loss [high — operational]: The net loss for the six months ended June 30, 2025, widened to $373,472 from $264,292 in the comparable 2024 period, despite a reduction in operating expenses, highlighting the impact of zero revenue.

Industry Context

The biotechnology and pharmaceutical sectors, where Totaligent likely operates given its financial struggles and need for significant R&D funding, are characterized by high risk, long development cycles, and substantial capital requirements. Success is often dependent on regulatory approvals and market adoption, with many companies facing similar challenges in securing ongoing financing and achieving commercial viability.

Regulatory Implications

As a company facing going concern issues and significant financial distress, Totaligent is under increased scrutiny. Failure to meet financial obligations or secure necessary funding could lead to delisting from exchanges or bankruptcy proceedings, impacting regulatory compliance and investor confidence.

What Investors Should Do

1. Avoid investment due to extreme financial distress.
2. Monitor future financing announcements closely.
3. Review management's strategy for revenue generation.

Key Dates

• 2025-06-30: End of Q2 2025 — Reported $0 revenue for the quarter and six months, a significant decline from 2024, and a widened net loss of $373,472 for H1 2025. Cash position improved to $62,626 due to convertible note proceeds.
• 2024-06-30: End of Q2 2024 — Reported $73,610 revenue for the quarter and $414,539 for the six months, with a net loss of $264,292 for H1 2024. This serves as a critical comparison point for the current period's severe revenue decline.
• 2024-12-31: End of Fiscal Year 2024 — Cash position was $22,128, highlighting the increase to $62,626 by June 30, 2025, primarily driven by new debt financing.

Glossary

Going Concern

An assumption that a company will continue to operate for the foreseeable future, typically at least 12 months from the reporting date. If substantial doubt exists, it must be disclosed. (Totaligent faces substantial doubt about its ability to continue as a going concern, indicating severe financial distress and potential for liquidation.)

Accumulated Deficit

The cumulative net losses of a company since its inception, less any net gains. It represents a negative retained earnings balance. (The company has an accumulated deficit of $2,180,835, showing a history of unprofitability and significant losses.)

Working Capital

The difference between a company's current assets and current liabilities. Positive working capital indicates the ability to meet short-term obligations. (Totaligent has negative working capital of $2,138,934, signifying a severe liquidity shortfall and inability to cover short-term debts with short-term assets.)

Convertible Notes Payable

Debt instruments that can be converted into a predetermined amount of equity in the issuing company. (Totaligent raised $230,000 from convertible notes, which temporarily improved its cash position but adds to its debt burden and potential future dilution.)

Year-Over-Year Comparison

Compared to the prior year, Totaligent has experienced a catastrophic decline in revenue, dropping from $73,610 in Q2 2024 to $0 in Q2 2025, and from $414,539 in H1 2024 to $0 in H1 2025. This has resulted in a complete loss of gross profit. While operating expenses have decreased, the net loss has widened to $373,472 for H1 2025. The company's financial condition has deteriorated significantly, evidenced by negative working capital and an accumulated deficit, despite a temporary cash boost from convertible notes.

Key Financial Figures

• $3.7 million — etplace on such date, was approximately $3.7 million. Shares of common stock held by each of

Filing Documents

• totaligent_10q.htm (10-Q) — 857KB
• totaligent_ex311.htm (EX-31.1) — 10KB
• totaligent_ex312.htm (EX-31.2) — 10KB
• totaligent_ex321.htm (EX-32.1) — 4KB
• totaligent_ex322.htm (EX-32.2) — 4KB
• 0001477932-25-005790.txt ( ) — 4054KB
• totaligent-20250630.xsd (EX-101.SCH) — 38KB
• totaligent-20250630_lab.xml (EX-101.LAB) — 210KB
• totaligent-20250630_cal.xml (EX-101.CAL) — 37KB
• totaligent-20250630_pre.xml (EX-101.PRE) — 179KB
• totaligent-20250630_def.xml (EX-101.DEF) — 91KB
• totaligent_10q_htm.xml (XML) — 677KB

– Financial Information

Part I – Financial Information 4 Item 1.

Financial Statements

Financial Statements 4 Consolidated Balance Sheets as of June 30, 2025 (unaudited) and December 31, 2024 F-1 Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024 (unaudited) F-2 Consolidated Statements of Stockholders' Deficit for the Three and Six Months Ended June 30, 2025 and 2024 F-3 F-4 Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 (unaudited) F-5 Notes to Unaudited Consolidated Financial Statements F-6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 5 Item 3. Qualitative and Quantitative Discussions about Market Risk 12 Item 4.

Controls and Procedures

Controls and Procedures 12

– Other Information

Part II – Other Information 13 Item 1.

Legal Proceedings

Legal Proceedings 13 Item 1A.

Risk Factors

Risk Factors 13 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 13 Item 3. Default Upon Senior Securities 13 Item 4. Mine Safety Disclosures 13 Item 5. Other Information 13 Item 6. Exhibits 14 2 Table of Contents SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This document contains certain statements of a forward-looking nature. Such forward-looking statements, including but not limited to statements regarding projected growth, trends and strategies, future operating and financial results, financial expectations and current business indicators are based upon current information and expectations and are subject to change based on factors beyond the control of the Company. Forward-looking statements typically are identified by the use of terms such as "look," "may," "should," "might," "believe," "plan," "expect," "anticipate," "estimate" and similar words, although some forward-looking statements are expressed differently. The accuracy of such statements may be impacted by a number of risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including but not limited to those set forth herein and in our Annual Report on Form 10-K. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by the federal securities laws, we undertake no obligation to update forward-looking information. Nonetheless, the Company reserves the right to make such updates from time to time by press release, periodic report or other method of public disclosure without the need for specific reference to this Report. No such update shall be deemed to indicate that other statements not addressed by such update remain correct or create an obligation to provide any other updates. 3 Table of Contents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial statements

Item 1. Financial statements TOTALIGENT, INC. FOR THE SIX MONTHS ENDED JUNE 30, 2025 INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Financial Statements

Financial Statements Consolidated Balance Sheets at June 30, 2025 (Unaudited) and December 31, 2024 F-1 Consolidated Statements of Operations (Unaudited) for the three and six months ended June 30, 2025 and 2024 F-2 Consolidated Statements of Stockholders' Deficit (Unaudited) for the three and six months ended June 30, 2025 and 2024 F-3 - F-4 Consolidated Statements of Cash Flows (Unaudited) for six months ended June 30, 2025 and 2024 F-5 Notes to Unaudited Consolidated Financial Statements F-6 4 Table of Contents TOTALIGENT, INC. AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS June 30, 2025 December 31, 2024 (Unaudited) ASSETS Current assets Cash $ 62,626 $ 22,128 Prepaid expenses 1,012 6,452 Total current assets 63,638 28,580 Property and equipment, net 38,206 66,354 Capitalized software 143,226 127,991 Total assets $ 245,070 $ 222,925 LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities Accounts payable $ - $ 7,000 Accrued compensation 988,697 988,697 Accrued interest 155,997 125,090 Convertible notes payable 911,335 681,335 Derivative liability 146,543 158,055 Total current liabilities 2,202,572 1,960,177 Total liabilities 2,202,572 1,960,177 Commitments and contingencies (Note 7) Stockholders' deficit Preferred stock, $ 0.01 par value; authorized – 10,000,000 shares Series D preferred stock, $ 0.01 par value; authorized – 1,000,000 shares; issued and outstanding – 576,562 and 713,750 shares at June 30, 2025 and December 31, 2024, respectively 5,766 7,138 Common stock, $ 0.001 par value; authorized – 500,000,000 shares; 211,101,313 shares issued and 211,101,313 and 172,913,813 outstanding as of June 30, 2025 and December 31, 2024, respectively 211,101 211,101 Shares to be issued 5,476 5,476 Additional paid-in capital 990 818,577 Accumulated deficit ( 2,180,835 ) ( 1,807,363 ) Treasury stock, 0 and 38,187,500 outstanding -

View Full Filing

View this 10-Q filing on SEC EDGAR